Microbiome-Induced Autoimmunity and Novel Therapeutic Intervention

4Citations
Citations of this article
11Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Microorganisms’ flora, which colonize in many parts of our body, stand out as one of the most important components for a healthy life. This microbial organization called microbiome lives in integration with the body as a single and whole organ/system. Perhaps, the human first encounters the microbial activity it carries through the immune system. This encounter and interaction are vital for the development of immune system cells that protect the body against pathogenic organisms and infections throughout life. In recent years, it has been determined that some disruptions in the host-microbiome interaction play an important role in the physiopathology of autoimmune diseases. Although the details of this interaction have not been clarified yet, the focus is on leaky gut syndrome, dysbiosis, toll-like receptor ligands, and B cell dysfunction. Nutritional regulations, prebiotics, probiotics, fecal microbiota transplantation, bacterial engineering, and vaccination are being investigated as new therapeutic approaches in the treatment of problems in these areas. This article reviews recent research in this area.

Cite

CITATION STYLE

APA

Evrensel, A. (2023). Microbiome-Induced Autoimmunity and Novel Therapeutic Intervention. In Advances in Experimental Medicine and Biology (Vol. 1411, pp. 71–90). Springer. https://doi.org/10.1007/978-981-19-7376-5_4

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free